DRCT vs ANGI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

DRCT

40.3
AI Score
VS
ANGI Wins

ANGI

46.7
AI Score

Investment Advisor Scores

DRCT

40score
Recommendation
HOLD

ANGI

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DRCT ANGI Winner
Forward P/E 5.1125 8.1103 DRCT
PEG Ratio 0 117.6 Tie
Revenue Growth -22.8% -10.9% ANGI
Earnings Growth 302.2% -67.1% DRCT
Tradestie Score 40.3/100 46.7/100 ANGI
Profit Margin -74.4% -22.4% ANGI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

DRCT 1M: -52.4% · 3M: -67.0% ANGI 1M: +28.3% · 3M: +11.6%

Current Technical Phase

DRCT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.4%), weak momentum, RSI 18

RSI (14): 17.9 · Price: $0.91

ANGI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.5% over 20 days), RSI 62

RSI (14): 62.1 · Price: $6.62

Fundamentals Snapshot

Metric DRCT ANGI
Market Cap — —
Forward P/E -0.1 13.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.2% -0.1%
Gross Margin 0.3% 1.0%
Operating Margin -0.4% 0.0%
EPS -197.09 -5.98
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ANGI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.